Right Resources Limited (ASX:RRE) has applied for quotation of 16.7 million fully paid ordinary shares issued on 17 July 2026 as part of a placement priced at AUD $0.09 per share, raising approximately $1.503 million in capital. This placement represents the first tranche of a two-part capital raise, with further tranches and director share allocations pending shareholder approval at an upcoming general meeting. Upon quotation, the company’s total quoted ordinary shares will reach 108.358 million.
Key Highlights
- Right Resources Limited (RRE) completed Tranche 1 of its capital raise, issuing 16.7 million shares at AUD $0.09 per share on 17 July 2026.
- The placement is expected to generate around AUD $1.503 million, with shares now quoted on the ASX.
- Tranche 2 involves 10.299 million shares, 13.499 million attaching placement options, and director share allocations, all subject to shareholder approval.
- Following this quotation, Right Resources will have 108.358 million quoted ordinary shares, alongside unquoted restricted securities and options.
Details of Tranche 1 Placement and Capital Injection
On 17 July 2026, Right Resources Limited successfully issued 16.7 million fully paid ordinary shares at AUD $0.09 each, marking a significant capital injection estimated at AUD $1.503 million gross proceeds. These shares have been applied for quotation on the ASX, substantially expanding the company’s quoted capital base.
The placement was initially announced on 9 July 2026, with the formal quotation application submitted on 17 July 2026, aligning with ASX protocols. The AUD $0.09 issue price sets a valuation benchmark for investors assessing the company’s market position and capital raise relative to recent performance.
Two-Tranche Capital Raise Structure and Shareholder Approval
The capital raise is structured in two tranches: Tranche 1 shares are now quoted, while Tranche 2 requires shareholder approval at an upcoming general meeting. Tranche 2 plans to issue an additional 10.299 million shares to current and new investors, enabling regulatory compliance and preserving shareholder voting rights on dilution matters.
Additionally, Right Resources will seek approval for issuing 13.499 million placement attaching options across both tranches. These options grant investors the right to subscribe for further shares in the future, serving as a secondary capital raising tool. Director participation is also proposed, with 3.333 million placement shares and 1.666 million attaching options subject to shareholder consent.
Director Participation and Governance Compliance
Directors are set to receive 3.333 million ordinary shares and 1.666 million placement options, contingent on shareholder approval at the forthcoming general meeting. This participation aligns management interests with shareholder value and demonstrates confidence in the company’s strategic direction.
Seeking shareholder consent for director allocations ensures transparency and adherence to ASX Listing Rules, mitigating conflicts of interest. The general meeting will provide shareholders an opportunity to evaluate these allocations within the broader capital raise context.
Expanded Quoted Capital Post-Placement
Following the quotation of Tranche 1 shares, Right Resources’ quoted ordinary shares total 108.358 million, a significant increase enhancing liquidity and potentially broadening the investor base.
The company also holds substantial unquoted securities, including 20.084 million restricted ordinary shares, 10 million options expiring 27 October 2028, 4.9 million options expiring 1 September 2028, and 3.79 million performance rights. These unquoted instruments may cause future dilution and often include vesting or exercise conditions, reflecting equity incentives for employees, directors, and investors.
Placement Attaching Options and Future Capital Raising Potential
The 13.499 million placement attaching options across both tranches offer Right Resources a secondary capital raising avenue if exercised by investors. Specific terms, exercise prices, and expiry dates will be disclosed separately, and investors should review these details upon release.
Options extend the capital raise beyond the initial placement, allowing additional funding at predetermined prices. They provide investors with upside potential if the share price rises above the exercise price while limiting downside to the option premium. This contingent dilution will be a key consideration for shareholders at the general meeting.
Pricing Strategy at AUD $0.09 Per Share
The AUD $0.09 placement price establishes a valuation reference for Right Resources at issuance, reflecting market perceptions of the company’s fundamentals and growth prospects as of early July 2026. This price was set in consultation with lead investors and brokers to balance capital raising success with shareholder dilution minimization.
While serving as a benchmark, this price represents a snapshot and may not indicate current or future fair value. Public information on immediate share price impact has not been disclosed.
Company Overview and Strategic Use of Raised Funds
Right Resources Limited (ABN 81649632744, ASX: RRE) is an ASX-listed company. Details on its operational focus and strategic objectives are not included in this announcement. Investors should consult the company’s broader disclosures, annual reports, and presentations for context on the capital raise’s intended deployment.
The AUD $1.503 million raised in Tranche 1, alongside potential proceeds from Tranche 2 and director allocations, will provide material capital for operational, exploratory, and corporate initiatives. Management will communicate fund allocation plans in shareholder updates, which investors should monitor closely.
Restricted Securities and Long-Term Capital Structure
Right Resources’ capital structure includes 20.084 million restricted ordinary shares (code RREAC), multiple classes of restricted options, and 3.79 million performance rights. These instruments typically have vesting or performance conditions and are used to align management and employee incentives with shareholder interests.
This framework balances incentivization with shareholder dilution considerations over time, reflecting common ASX-listed company practices.
Next Steps and Shareholder Meeting Timeline
Following the quotation of Tranche 1 shares on 17 July 2026, Right Resources will convene a general meeting to seek shareholder approval for Tranche 2 shares, attaching options, and director allocations. The meeting date will be announced in accordance with the Corporations Act 2001 and ASX Listing Rules.
Shareholders should watch for announcements detailing the meeting agenda and explanatory materials to make informed voting decisions. The outcomes will determine the final capital raise size, share and option issuance, and dilution impact.